Next generation sequencing of HCC from European and Asian HCC cohorts. Back to p53 and Wnt/β-catenin

Journal of Hepatology

Volumn 58, Issue 3, 2013, Pages 622-624

  Teufel, Andreas ^a   Marquardt, Jens U ^a   Galle, Peter R ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; INTERFERON REGULATORY FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; RAS PROTEIN; WNT PROTEIN;

CHROMATIN ASSEMBLY AND DISASSEMBLY; EXOME; GENE DELETION; GENE DOSAGE; GENE INACTIVATION; GENE SEQUENCE; GENETIC ASSOCIATION; HEPATITIS B VIRUS; HOMOZYGOSITY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NOTE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 84874111345     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.10.006     Document Type: Note

References (15)

1. A. Teufel, F. Staib, S. Kanzler, A. Weinmann, H. Schulze-Bergkamen, and P.R. Galle Genetics of hepatocellular carcinoma World J Gastroenterol 13 2007 2271 2282
2. J.S. Lee, I.S. Chu, J. Heo, D.F. Calvisi, Z. Sun, and T. Roskams Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676
3. J.U. Marquardt, P.R. Galle, and A. Teufel Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies J Hepatol 56 2012 267 275
4. C. Guichard, G. Amaddeo, S. Imbeaud, Y. Ladeiro, L. Pelletier, and I.B. Maad Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma Nat Genet 44 2012 694 698
5. A. Fujimoto, Y. Totoki, T. Abe, K.A. Boroevich, F. Hosoda, and H.H. Nguyen Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators Nat Genet 44 2012 760 764
6. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
7. A.L. Cheng, Y.K. Kang, Z. Chen, C.J. Tsao, S. Qin, and J.S. Kim Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 2009 25 34
8. A. Teufel, J.U. Marquardt, F. Staib, and P.R. Galle Snapshot liver transcriptome in hepatocellular carcinoma J Hepatol 56 2012 990 992
9. L.D. Wood, D.W. Parsons, S. Jones, J. Lin, T. Sjoblom, and R.J. Leary The genomic landscapes of human breast and colorectal cancers Science 318 2007 1108 1113
10. J.C. Nault, and J. Zucman-Rossi Genetics of hepatobiliary carcinogenesis Semin Liver Dis 31 2011 173 187
11. J.B. Andersen, V.M. Factor, J.U. Marquardt, C. Raggi, Y.H. Lee, and D. Seo An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer Sci Transl Med 2 2010 54ra77
12. E. Hashimoto, and K. Tokushige Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? Hepatol Res 42 2012 1 14
13. E. Romano, G.K. Schwartz, P.B. Chapman, J.D. Wolchock, and R.D. Carvajal Treatment implications of the emerging molecular classification system for melanoma Lancet Oncol 12 2011 913 922
14. H. Tsao, L. Chin, L.A. Garraway, and D.E. Fisher Melanoma: from mutations to medicine Genes Dev 26 2012 1131 1155
15. N. Normanno, S. Tejpar, F. Morgillo, A. De Luca, E. Van Cutsem, and F. Ciardiello Implications for KRAS status and EGFR-targeted therapies in metastatic CRC Nat Rev Clin Oncol 6 2009 519 527